Independent Research Analysts Give Carl Zeiss Meditec (ETR:AFX) a €93.00 Price Target

Carl Zeiss Meditec (ETR:AFX) received a €93.00 ($108.14) target price from stock analysts at Independent Research in a research report issued on Tuesday, Borsen Zeitung reports. The brokerage currently has a “sell” rating on the stock. Independent Research’s price target would indicate a potential downside of 17.33% from the stock’s previous close.

Other research analysts also recently issued research reports about the company. Deutsche Bank set a €123.00 ($143.02) target price on Carl Zeiss Meditec and gave the stock a “buy” rating in a report on Monday. HSBC set a €109.00 ($126.74) price target on Carl Zeiss Meditec and gave the company a “neutral” rating in a research report on Tuesday. Kepler Capital Markets set a €80.00 ($93.02) price objective on Carl Zeiss Meditec and gave the stock a “sell” rating in a research note on Friday. DZ Bank reaffirmed a “neutral” rating on shares of Carl Zeiss Meditec in a report on Friday, October 25th. Finally, Berenberg Bank set a €93.00 ($108.14) target price on shares of Carl Zeiss Meditec and gave the company a “neutral” rating in a research note on Friday. Two investment analysts have rated the stock with a sell rating, four have given a hold rating and two have given a buy rating to the company. Carl Zeiss Meditec presently has an average rating of “Hold” and a consensus target price of €100.86 ($117.28).

Shares of Carl Zeiss Meditec stock opened at €112.50 ($130.81) on Tuesday. The company has a quick ratio of 3.09, a current ratio of 4.11 and a debt-to-equity ratio of 4.55. The firm has a market cap of $10.22 billion and a P/E ratio of 65.71. Carl Zeiss Meditec has a fifty-two week low of €65.80 ($76.51) and a fifty-two week high of €112.70 ($131.05). The business has a 50-day moving average price of €103.31 and a 200 day moving average price of €97.70.

Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.

Featured Article: How accurate is the Rule of 72?

Analyst Recommendations for Carl Zeiss Meditec (ETR:AFX)

Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.